Results 11 to 20 of about 96,811 (318)

Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach

Journal of Cardiothoracic Surgery, 2022
Background Introduction of Bare Metal Stents (BMS) was itself a revolutionary step in the history of the medical industry; however, Drug Eluting Stents (DES) maintained its superiority over BMS in every aspect from restenosis rate to late lumen loss. The
Sadia Hassan, Murtaza Najabat Ali, Bakhtawar Ghafoor   +2 more
doaj   +2 more sources

Drug-Eluting Stents: Technical and Clinical Progress

Biomimetics, 2023
Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous revascularization procedures.
Maciej Koźlik, Jan Harpula, Piotr J. Chuchra, M. Nowak, W. Wojakowski, P. Gąsior   +5 more
semanticscholar   +1 more source

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence

Journal of Clinical Medicine, 2023
Iterations in stent technologies, advances in pharmacotherapy, and awareness of the implications of implantation techniques have markedly reduced the risk of stent failure, both in the form of stent thrombosis (ST) and in-stent restenosis (ISR). However,
F. Condello, C. Spaccarotella, S. Sorrentino, C. Indolfi, G. Stefanini, A. Polimeni   +5 more
semanticscholar   +1 more source

Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Percutaneous coronary intervention of calcified lesions was associated with worse outcomes in the era of bare‐metal and first‐generation drug‐eluting stents. Data on percutaneous coronary intervention of calcified lesions with newer‐generation
R. Hemetsberger, M. Abdelghani, R. Toelg, N. Mankerious, A. Allali, H. García-García, S. Windecker, T. Lefévre, S. Saito, T. Slagboom, D. Kandzari, J. Koolen, R. Waksman, G. Richardt   +13 more
semanticscholar   +1 more source

Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease

Circulation, 2020
Supplemental Digital Content is available in the text. Background: Long-term comparative outcomes after percutaneous coronary intervention (PCI) with drug-eluting stents and coronary-artery bypass grafting (CABG) for left main coronary artery disease are
Duk‐Woo Park, Jung‐Min Ahn, Hanbit Park, S. Yun, Do-Yoon Kang, P. Lee, Young-Hak Kim, D. Lim, S. Rha, Gyung-Min Park, H. Gwon, Hyo‐Soo Kim, I. Chae, Y. Jang, M. Jeong, S. Tahk, K. Seung, Seung‐Jung Park   +17 more
semanticscholar   +1 more source

Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents

Circulation, 2020
Supplemental Digital Content is available in the text. Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with drug-eluting stents remains uncertain.
Safi U. Khan, Maninder Singh, Shahul Valavoor, M. U. Khan, Ahmad N. Lone, M. Khan, M. Khan, P. Mani, S. Kapadia, E. Michos, G. Stone, A. Kalra, Deepak L. Bhatt   +12 more
semanticscholar   +1 more source

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review

Molecules, 2020
Controlled drug delivery is a matter of interest to numerous scientists from various domains, as well as an essential issue for society as a whole. In the treatment of many diseases, it is crucial to control the dosing of a drug for a long time and thus ...
I. Rykowska, I. Nowak, R. Nowak
semanticscholar   +1 more source

Pharmacokinetic analysis after implantation of everolimus-eluting self-expanding stents in the peripheral vasculature [PDF]

, 2012
Background: A novel self-expanding drug-eluting stent was designed to release everolimus 225 mu g/cm(2) to prevent restenosis following peripheral arterial intervention.
Hausegger, Klaus A, Koppensteiner, Renate, Lammer, Johannes, Mellon, Rajeev M, Scheinert, Dierk, Schroë, Herman, Schwartz, Lewis B, Vermassen, Frank   +7 more
core   +2 more sources

Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]

, 2006
Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger, Boeckstegers, Peter, Heitzer, Thomas, Hoffmann, Rainer, Köster, Ralf, Pohl, Tilmann   +5 more
core   +2 more sources

A mixed treatment comparison for short- and long-term outcomes of bare metal and drug eluting coronary stents [PDF]

, 2016
Background The increasing use of drug eluting stents in interventional cardiology calls for assessment of their efficacy and safety, both among drug eluting and bare-metal stents, in the context of rational decision making.
Dias, Sofia, Petrou, Panagiotis
core   +2 more sources